Correlation Between Pfizer and Evotec SE
Can any of the company-specific risk be diversified away by investing in both Pfizer and Evotec SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Evotec SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Evotec SE, you can compare the effects of market volatilities on Pfizer and Evotec SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Evotec SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Evotec SE.
Diversification Opportunities for Pfizer and Evotec SE
Very good diversification
The 3 months correlation between Pfizer and Evotec is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Evotec SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evotec SE and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Evotec SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evotec SE has no effect on the direction of Pfizer i.e., Pfizer and Evotec SE go up and down completely randomly.
Pair Corralation between Pfizer and Evotec SE
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the Evotec SE. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 3.38 times less risky than Evotec SE. The stock trades about -0.13 of its potential returns per unit of risk. The Evotec SE is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 710.00 in Evotec SE on September 13, 2024 and sell it today you would earn a total of 224.00 from holding Evotec SE or generate 31.55% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. Evotec SE
Performance |
Timeline |
Pfizer Inc |
Evotec SE |
Pfizer and Evotec SE Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Evotec SE
The main advantage of trading using opposite Pfizer and Evotec SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Evotec SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will offset losses from the drop in Evotec SE's long position.Pfizer vs. AbbVie Inc | Pfizer vs. Merck Company | Pfizer vs. Eli Lilly and | Pfizer vs. Bristol Myers Squibb |
Evotec SE vs. Pacira BioSciences, | Evotec SE vs. Collegium Pharmaceutical | Evotec SE vs. Prestige Brand Holdings | Evotec SE vs. Phibro Animal Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
CEOs Directory Screen CEOs from public companies around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |